390 related articles for article (PubMed ID: 29896858)
21. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
[TBL] [Abstract][Full Text] [Related]
22. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of BK virus replication in the first year following renal transplantation.
Costa C; Bergallo M; Astegiano S; Terlizzi ME; Sidoti F; Segoloni GP; Cavallo R
Nephrol Dial Transplant; 2008 Oct; 23(10):3333-6. PubMed ID: 18503098
[TBL] [Abstract][Full Text] [Related]
24. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
Alméras C; Vetromile F; Garrigue V; Szwarc I; Foulongne V; Mourad G
Transpl Infect Dis; 2011 Apr; 13(2):101-8. PubMed ID: 21371220
[TBL] [Abstract][Full Text] [Related]
25. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
[TBL] [Abstract][Full Text] [Related]
26. BK virus salivary shedding and viremia in renal transplant recipients.
Sarmento DJS; Palmieri M; Galvão GS; Tozetto-Mendoza TR; Canto CMD; Pierrotti LC; David-Neto E; Agena F; Gallottini M; Pannuti CS; Fink MCD; Braz-Silva PH
J Appl Oral Sci; 2019 Jan; 27():e20180435. PubMed ID: 30673031
[TBL] [Abstract][Full Text] [Related]
27. Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy.
Chung BH; Hong YA; Kim HG; Sun IO; Choi SR; Park HS; Lee SH; Choi BS; Park CW; Choi YJ; Kim YS; Yang CW
Transpl Int; 2012 Jun; 25(6):687-95. PubMed ID: 22509924
[TBL] [Abstract][Full Text] [Related]
28. Variability in assessing for BK viremia: whole blood is not reliable and plasma is not above reproach - a retrospective analysis.
Agrawal N; Echenique IA; Meehan SM; Limaye AP; Cook L; Chang A; Harland RC; Javaid B; Kadambi PV; Matushek S; Williams J; Josephson MA
Transpl Int; 2017 Jul; 30(7):670-678. PubMed ID: 28295760
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: a single-center retrospective analysis.
Alexander RT; Langlois V; Tellier R; Robinson L; Hébert D
Pediatr Transplant; 2006 Aug; 10(5):586-92. PubMed ID: 16856995
[TBL] [Abstract][Full Text] [Related]
30. Monitoring the BK virus in liver transplant recipients: a prospective observational study.
Demir-Onder K; Avkan-Oguz V; Unek T; Sarioglu S; Sagol O; Astarcioglu I
Exp Clin Transplant; 2014 Oct; 12(5):429-36. PubMed ID: 24679112
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
[TBL] [Abstract][Full Text] [Related]
32. Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients.
Myint TM; Turner RM; Craig JC; Cross NB; Kable K; Nankivell BJ; Chapman JR; Webster AC; O'Connell P; Dwyer DE; Jeoffreys N; Roger SD; Wong G
Clin Transplant; 2013; 27(5):E571-9. PubMed ID: 23952788
[TBL] [Abstract][Full Text] [Related]
33. Detection of BKV encoded mature MicroRNAs in kidney transplant patients: Clinical and biologic insights.
Huang Y; Zeng G; Randhawa PS
J Clin Virol; 2019 Oct; 119():6-10. PubMed ID: 31422199
[TBL] [Abstract][Full Text] [Related]
34. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
[TBL] [Abstract][Full Text] [Related]
35. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
37. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
[TBL] [Abstract][Full Text] [Related]
38. Monitoring of BK virus in transplant patients of the renal unit of the Perrando Hospital, Chaco, Argentina.
Marinic K; Sinchi J; Gómez M; Díaz R; Grillo S; Habegger-de Sorrentino A
Nefrologia; 2014 Nov; 34(6):799-800. PubMed ID: 25415580
[No Abstract] [Full Text] [Related]
39. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center.
Mindlova M; Boucek P; Saudek F; Skibova J; Jedinakova T; Lipar K; Adamec M; Hirsch HH
Clin Transplant; 2012; 26(2):267-74. PubMed ID: 21854452
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV-related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA.
van Doesum WB; Gard L; Knijff LWD; Niesters HGM; van Son WJ; Stegeman CA; van den Berg A; Groen H; van den Born J; Riezebos-Brilman A; Sanders JS
Transpl Infect Dis; 2022 Dec; 24(6):e13927. PubMed ID: 35916729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
